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Foamy virus (FV) Bel1/Tas transactivators act as key regulators of gene expression and directly bind DNA Bel1 response elements
(BREs) in both the internal (IP) and 5VLTR promoters. Here, we report the mapping and the virus species specificity of the nonhomologous
feline foamy virus (FFV) BREs in both promoters. The data indicate that FFV Bel1 did not bind the primate FV IP.BRE and that primate FV
Bel1 was not capable of binding the FFV IP.BRE. In addition, we show that the C-terminal activation domain of FFV Bel1 does not
contribute to DNA binding because a C-terminal trans-dominant negative FFV Bel1 mutant was still able to bind to both promoters.
D 2003 Elsevier Inc. All rights reserved.Keywords: Cat foamy virus; Spumavirus; Bel1 transactivatorIntroduction
Foamy virus (FV) gene expression is strictly dependent
on their transactivator proteins called Bel1/Tas for the
primate prototype FV (PFV). In contrast to other complex
retroviruses (Cullen, 1991), the presence of a functionally
active, internal promoter (IP) is unique to FVs besides the
conventional LTR promoters (for reviews, see Coffin et al.,
1997; Linial, 1999). The transcriptional activities of both
promoters strictly depend on the viral transactivator. The IP
has been suggested to form a positive feedback loop for
viral gene expression in which the basal activity of the IP is
increased by its own gene product (Lo¨chelt et al., 1993).
The nuclear Bel1/Tas protein of prototypic PFV binds DNA
target sites directly and consists of at least two functional
domains, an N-terminal/central DNA binding and a C-
terminal activation domain (Garrett et al., 1993; He et al.,0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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1275 York Avenue, New York, NY 10021, USA.1993; He et al., 1996; Kang et al., 1998). The feline foamy
virus (FFV) transactivator has not been characterized in any
detail. But it has been reported that FFV Bel1 is almost
exclusively expressed from the IP (Bodem et al., 1998a,
1998b). Because of its low degree of protein homology of
18% to other FV transactivators (Meyering and Linial,
2002), it was our aim to study whether transactivation and
DNA binding capabilities were functionally conserved in
FFV Bel1.Results and discussion
In initial experiments, the transactivation capacity of the
LTR promoter plasmids with defined C-terminal Bel1 dele-
tions were determined in vivo by luciferase (luc) reporter
assays containing the region from 130 to +30 of the 5VLTR
promoter (Fig. 1A). The luciferase activity was normalized
for the expression of a cotransfected SV40-h-galactosidase
(h-gal) expression plasmid (Winkler et al., 1997). The FFV
DC20-Bel1 mutant that lacks the last C-terminally located
20 amino acids was cloned by PCR (Bel1s 5V-GGAAGATC-
TATGGCTTCAAAATAC - 3 V, B e l 1 -DC - 2 0 , 5 V-
TACTTCTTCTTCCATGATTCCCCC-3V) into the same vec-
tor context as wild-type (wt) FFV Bel1 (Winkler et al.,
1997). FFV-DC20-Bel1 failed to support transactivation of
Fig. 1. (A) Diagram of the FFV 5VLTR promoter regions cloned into pGL2-bas. Promoter regions relative to the transcription start site are shown. (B)
Cotransactivation of the FFV 5VLTR luciferase minigene reporter plasmids containing promoter regions from 130 to +30 with FFV Bel1 protein.
Each pBK-CMV-Bel1 expression plasmid was cotransfected with FFV 5VLTR-luc into CRFK cells and luc activity was determined after 48 h and
normalized for transfection efficiency. The control transfection with plasmid pGL2-LTR was done without any FFV Bel1 expression plasmids (first
line). Two different recombinant plasmid clones A and B of DC20-Bel1 mutant were used (lines numbered 2 and 3). The data represent the mean F
SD for three experiments.
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that the last 20 residues are essential for transactivation. If
these FFV Bel1 mutants were still able to bind to the
promoter, they should act as trans-dominant negative pro-
teins in the FFV LTR promoter-mediated transactivation. To
prove this assumption, Crandell feline kidney cells (CRFK)
cells were transfected with both wt and the DC20-Bel1
mutant. The transactivation capacity of the 5VLTR promoter
was determined by luc assays (Winkler et al., 1997) and
normalized for h-gal expression. As shown in Fig. 1B
(lower part), DC20-Bel1 repressed transactivation of the
FFV LTR promoter by wt Bel1 about 150fold. The expres-
sion of the mutant Bel1 proteins was analyzed by western
blotting and found to be of similar levels to the wild type
construct (data not shown). This result proves that the C-
terminal region is crucial for promoter activation and
suggests that DC20-Bel1 was still able to bind to the Bel1
response elements (BRE) in the 5VLTR promoter.
To determine the regions of the FFV promoters that are
required for promoter activity and transactivation, LTR and
IP deletion fragments were cloned into luc reporter plasmids
pGL2-bas (Promega). These minigene reporter constructs
and CMV-Bel1 (Winkler et al., 1997) were cotransfected
into CRFK cells, harvested 2 days post transfection, and
analyzed for luc activity. Even LTR constructs that
contained only the region from 100 to +30 (Fig. 1A)
showed levels of transactivation similar to wt activity. The
data support the conclusion that FFV BREs and potential
binding sites for cellular transcription factors required for
Bel1-mediated transactivation should be located within this
promoter region.To further study the mechanism of transactivation by
FFV Bel1, electrophoretic mobility shift assays (EMSAs)
were carried out with promoter regions derived from the
FFV LTR. Bel1 was fused to the maltose-binding protein
(MBP) of E. coli, expressed and purified to homogeneity
according to the manufacturer’s protocol. EMSAs were
performed as described before (Kang et al., 1998). Binding
of MBP-Bel1 was observed when FFV LTR promoter
probes from nucleotide 80 to +30 relative to transcription
start site were used (Figs. 1A and 2A, lanes 1–5). In
contrast, native MBP alone did not bind to any DNA probe
used in this study. In addition, heterologous DNA sequences
failed to bind MBP-Bel1 under the conditions used and
supershifts using anti-MBP-antibodies shifted Bel1-DNA
complexes as expected (data not shown). To analyze wheth-
er DC20-Bel1 did indeed bind the FFV BRE, EMSAs with a
DN20–DC20 MBP-Bel1deletion were carried out (Fig. 2A,
lanes 7–10). The resulting data showed that neither the first
20 nor the last 20 amino acids were required for DNA
binding.
The transactivation of the internal FFV promoter by Bel1
was characterized by cloning three promoter regions from
254 to +59, relative to the IP start site (Winkler et al.,
1997) into a luc promoter reporter plasmid. The promoter
regions from 254 to +59 and 160 to +59 showed similar
activity, whereas the region from 110 to +59 was not
transactivated by Bel1 (data not shown). The last results
might be explained by either the absence of a BRE or the
deletion of a binding site of an essential cellular factor. To
rule out the latter, mapping of the FFV Bel1 binding site
within IP was required.
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Fig. 2. (A) Binding of recombinant FFV Bel1 protein to the 5VFFV LTR promoter. EMSAs with the 32P-labeled 5VLTR promoter region from 70 to +30 with
increasing concentrations of FFV MBP-Bel1 protein. A control titration was carried out without any MBP-Bel1 (lane 1). The retardation obtained with intact
and purified MBP-Bel1 is shown in lanes 2–6, that of mutant-D20N-C20-Bel1 binding with comparable amounts of MBP-Bel1 in lanes 7–10. (B) Supershift
EMSA with monoclonal antibody directed against MBP-Bel1. The 32P-labeled IP.BRE promoter region from 70 to +30 (lane 1) was incubated with MBP-
Bel1 (lane 2). The specificity of the reaction was shown by supershifting the complex with monoclonal MBP antibody (lane 3).
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promoter, EMSAs using MBP-Bel1 and probes from the IP
were performed. Monoclonal MBP antibodies directed
against Bel1 were used to demonstrate the specificity of
FFV Bel1 binding to the IP.BRE in a supershift EMSA (Fig.
2B). The data showed that the probe resulted in a supershift
upon addition of the MBP antibody proving the specificity
of MBP-Bel1 binding. We conclude that the observed
IP.BRE DNA mobility shift was due to the MBP-Bel1
fusion protein.
Shorter 5VLTR promoter regions were used to delineate
the Bel1-DNA binding site. A mobility shift was still
observed with a promoter region from 70 to +30 (Fig.
1A). The region downstream of the TATA box did not
contribute to Bel1 binding and further experiments with
DNA fragments from 100 to 50 and from 70 to 22
resulted in the formation of DNA-Bel1 complexes (Fig.
1A). Thus, the minimal BRE of FFV LTR was mapped to an
overlapping DNA region from 70 to 50 with the BRE
sequence 5V-AACTTTAACTTTAGTTGC-3V. The control
fragment from 50 to +30 failed to bind Bel1 (Fig. 1A).
A DNA fragment encompassing nucleotides 60 to +22
showed an intermediate phenotype and the control fragment
from 50 to +30 failed to bind Bel1 (Fig. 1A).
To precisely determine the FFV BRE within the 5VLTR
and IP, DNase I and Exo III nuclease protection analyses
were performed with the LTR promoter region from 80 to
+20. This DNA fragment was cloned into PCR-II vector
(Invitrogen) and amplified with purified 32P-labeled T7promoter and M13rev vector primer. The resulting PCR
product was gel-purified and the incorporated radioactivity
was measured. The end-labeled DNA was incubated with
purified MBP-Bel1 protein for 30 min under the same
conditions as used for the EMSAs, followed by nuclease
digestion for 1.5 min using 1 U DNase I at 25 jC. The
resulting fragments were precipitated and separated on an
8% urea-polyacrylamide gel under denaturing conditions.
Significantly, the protected region from to 66 to 51, and
two major DNase I-hypersensitive sites at positions 66,
51, 29, and 24 resulted from Bel1 binding (Fig. 3A).
The same result was obtained in an Exo IIII protection assay
(data not shown). In conclusion, purified Bel1 protein
concentrations of 60 ng were required to protect the
LTR.BRE against DNase I digestion. This result demon-
strates that the FFV Bel1 protein indeed directly bound to
the LTR.BRE. The data illustrate that the mechanism of
directly binding of BRE DNA targets by Bel1/Tas trans-
activators is conserved throughout the complex FV group.
This binding occurs although both the Bel1/Tas proteins and
the BREs show very low if any homology to the primate
FVs (GenBank accession no. AJ223851).
DNase I footprint analysis was used to map the precise
position of the FFV IP.BRE. A DNA fragment from 160
to +59 (relative to the second cap site of the FFV genome)
was cloned into pCRII, amplified with a labeled antisense
primer, and gel-purified. The binding reaction and the DNase
I treatment were carried out exactly as described above
using probe of comparable specific activity. Fig. 3B shows
Fig. 4. Species specificity of BRE binding by FFV Bel1. Purified FFV
MBP-Bel1 did not bind to the 32P-labeled PFV IP.BRE as probe from 191
to 105 (lanes 9–12). The controls with PFV GST-Bel1 (lane 8) and the
FFV 5VLTR probe from 70 to +30 showed positive reactions as expected.
The inability of PFV GST-Bel1 to bind to the FFV LTR is shown in lane 2.
Fig. 3. DNase I protection assay on the 32P-labeled FFV LTR region from
genomic position 979 to 1210 (A) and the IP.BRE (B) as probe from
positions 8794 to 9054 in the presence of purified MBP-Bel1. The labeled
DNA probe was incubated with 60 and 30 ng MBP-Bel1 and subsequently
digested with DNase I (lanes 3 and 4); control reactions were done without
DNase I (lane 1) or MBP-Bel1 (lane 2). Filled and empty arrows mark
hypersensitive and protected sites, respectively. The fragment size and the
nucleotide positions were determined by a sequencing reaction.
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AAAGGCCAC-3V) of the FFV IP.BRE. This region had
only a limited homology to the FFV LTR binding site. The
data indicate that the IP.BRE presents a high-affinity
binding site in comparison to the LTR.BRE because just
half of the concentration of the Bel1 protein was sufficient
to protect the IP.BRE.
As reported previously (Winkler et al., 1997), FFV Bel1
was not able to transactivate the PFV promoter in vivo and,
in addition, PFV Bel1 failed to activate the FFV LTRpromoter. To analyze the underlying mechanism, EMSAs
were done with either FFV or PFV Bel1 and, in addition,
either FFVor PFV promoter probes. A probe specific for the
IP (from 191 to 105) of PFV was labeled with 32P and
incubated with FFV Bel1 under the same conditions used
for the EMSA. The FFV LTR promoter probe served as a
positive control reaction (Fig. 4, lanes 3–6). The gel
retardation shifts (lanes 9–12) of FFV Bel1 failed to bind
to the PFV IP region. In the converse experiment, PFV Bel1
(Fig. 4, lane 2) did not bind to the FFV promoter element
revealing that the inability of cross-transactivation was due
to the specific DNA binding properties of FFV and PFV
Bel1 proteins. To test virus species specificity of the Bel1
binding in vivo, yeast-one hybrid experiments were carried
out with the FFV IP region from 245 to +59 cloned into
pLGSD5 as target DNA and a FFV (cloned into pYCplacIII)
or a PFV Bel1 expression plasmid (Venkatesh and Chinna-
durai, 1993). The h-gal activity was increased 50-fold upon
cotransfection of FFV Bel1 and the reporter plasmid,
whereas the PFV Bel1 protein did not result in a significant
transactivation of the FFV reporter construct. These results
show that the transactivator domain of FFV was functional
in yeast cells and that PFV Bel1 failed to bind to the FFV IP.
Future tasks will include the analysis of the role of the FFV
Bet protein that has recently been suggested to act as a
molecular switch in PFV replication (Meyering and Linial,
2002).
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